Key facts
- Vytalize Health’s last known valuation is $137.2M (Apr 2022).
- It has raised $286.1M; the latest was Later Stage VC ($55.0M) in Jul 2025.
- Notable investors include Plug and Play Tech Center, KittyHawk, Monroe Capital, Kawn Ventures, Beresford Ventures — 19 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 19 names
- ·Watchlist + deal alerts for Vytalize Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Vytalize Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Vytalize Health
Developer of a VBC enablement platform intended to help primary care doctors strengthen relationships with their patients through data-driven and personalized care. The company's platform offers care delivery models tailored specifically to Medicare patients to manage their chronic conditions in collaboration with their doctors and provides software with value-based incentives, smart technology, and a virtual clinic, enabling small and large independent practices to succeed in value-based care arrangements.
- Sector
- Healthcare
- HQ
- Hoboken, NJ, United States
- Founded
- 2014
- Employees
- 219
- Website
- vytalizehealth.com/
- Ownership
- Privately Held (backing)
Vytalize Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Vytalize Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Vytalize Health in its N-PORT filings yet. We sweep new filings monthly.